Skip to content

 

Rapidly translating data into patient impact

We are the first and only company to identify the mechanisms driving complex, chronic diseases and discover the biomarkers that stratify patients with that underlying biology – maximizing the success of healthcare, diagnostics, and drug development.

IMPROVING HEALTH OUTCOMES

 Predicting lifetime risk of disease in patients

  Selecting the most effective treatments

  Preventing major chronic diseases

INCREASING DRUG SUCCESS

 Discovering novel & protective targets

  Accelerating & de-risking clinical trials

  Mapping trials & treatments to patients

60+
Across >60 chronic diseases

5B+
To improve 5.4 billion lives

80%
Reducing >80% of health costs

Aging

Allergy

Cardiovascular

Dermatology

Gastrointestinal

Immunology

Infectious

Metabolic

Neurology

Psychiatry

Respiratory

Women's health

Predictive & personalized healthcare 1-min

Predictive & personalized healthcare

Chronic diseases present the biggest challenge in global healthcare. We develop mechanostics® – a new generation of more accurate diagnostic, prognostic, and therapy selection tools to identify causal biology and intervene earlier than ever before. 

  Predicting disease risk

   Treating mechanistic causes

   Prevent onset and progression

Improving outcomes, increasing healthspan, and reducing costs.

    

Successful & effective drug development

We're transforming the ability to successfully develop better, more personalized treatments faster for complex diseases.

We maximize probability of success throughout every stage of drug discovery and development. Eliminating risk with mechanistic insights and stratification biomarkers that unlock the relationships between patients, mechanisms, targets, and treatments.

   

Successful & effective drug development 1-min
Stratifying chronic disease biology 1-min

Stratifying chronic disease biology

Our insights hold the key to reducing the global burden of chronic diseases and improving health for billions of people. 

Powered by hypothesis-free combinatorial analytics, our platform is built for complex biology - identifying disease signatures in patient subgroups that are invisible to other analytical approaches.

We achieve a unique mechanistic understanding of disease – determining causality and enabling patient stratification for personalized diagnosis, treatment and prevention in all diseases.

This is precision medicine, for everyone.

The PrecisionLife difference

We're making precision medicine possible in the world's most common and costly diseases.
Generating unprecedented biological insights to enable personalized diagnosis, treatment, prediction & prevention.

Analytics

Unique data access

Unparalleled access to multimodal patient data across chronic diseases through partnerships with biobanks, disease charities, research consortia and global healthcare systems.

Data

Combinatorial analytics

Science that goes far beyond the capabilities of AI or GWAS. Generating 10x the signal from 10% of the data to find the hidden biology underpinning complex diseases.

Insights

Actionable insights

The deepest disease biology insights, mechanistic patient stratification, and biomarker discovery to predict risk of disease earlier and drive more effective diagnostics and treatments.

Let's talk

Patients are counting on us

We're always looking for new partners to achieve better health for patients, faster.

Contact us to request more information or discuss a collaboration.